Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.862 USD | -8.53% | +0.00% | -8.18% |
May. 10 | Arcadium Lithium Applies to Cease to be a Reporting Issuer in Canada | MT |
May. 07 | Arcadium Lithium Q1 Adjusted Earnings Decline, Revenue Rises | MT |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- The company is in a robust financial situation considering its net cash and margin position.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Over the past year, analysts have regularly revised upwards their sales forecast for the company.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company's enterprise value to sales, at 4.35 times its current sales, is high.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-8.18% | 5B | B+ | ||
+17.73% | 66.69B | A- | ||
+1.61% | 49.2B | A- | ||
+16.33% | 41.24B | B+ | ||
+18.68% | 25.89B | A- | ||
+12.78% | 19.81B | C+ | ||
-21.87% | 15.86B | A- | ||
-10.29% | 15.23B | C+ | ||
+2.32% | 15.35B | B+ | ||
-22.30% | 13.36B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ALTM Stock
- LTHM Stock
- Ratings LIVENT